Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Medicine|April 15, 2026
Hepatic-Differentiated Subpopulation in Clear Cell Renal Cell Carcinoma: A Multi-Omics Analysis of Tumors With Lymphovascular InvasionShugo Yajima, Yuichiro Tsukada, Riu Yamashita, et al.
International Journal of Clinical Oncology|June 10, 2025
Physical activity and cancer biology: a narrative review of molecular mechanisms and introduction of the SCRUM-MONSTAR LIFELOG studyShugo Yajima, Shin Kobayashi, Tadayoshi Hashimoto, et al.
Journal of Robotic Surgery|February 9, 2026
A multi‑criteria decision analysis comparing robot‑assisted, laparoscopic, and open radical cystectomy using large-scale Japanese nationwide databasesHiroshi Fukushima, Soichiro Yoshida, Shugo Yajima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2025
Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in JapanShugo Yajima, Shinro Hata, Naoya Masumori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 8, 2026
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying EffectsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Urology and Nephrology|April 21, 2026
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinationsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2021
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomyNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
World Journal of Urology|March 21, 2024
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysisNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
International Journal of Clinical Oncology|February 7, 2025
Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testingShin Kobayashi, Yoshiaki Nakamura, Tadayoshi Hashimoto, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
Pageof 11